» Articles » PMID: 12646171

A Novel Mammalian Endoplasmic Reticulum Ubiquitin Ligase Homologous to the Yeast Hrd1

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2003 Mar 21
PMID 12646171
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The yeast hHrd1 is a ubiquitin-protein ligase (E3) involved in ER-associated degradation. It was originally identified by genetic methods as an E3 of the yeast cholesterol biosynthetic enzyme HMG-CoA reductase (HMGR). We report the identification and cloning of a human homologue of Hrd1 (hHrd1). Immunofluorescence imaging confirms that the endogenous hHrd1 resides in the ER and in vitro assay demonstrates that it has a ubiquitin-ligase activity. However, the homology between the human and yeast Hrd1 is limited to the N-terminal domain of the proteins, and hHrd1 does not appear to be involved in the degradation of mammalian HMGR.

Citing Articles

An integrated analysis of multiple datasets reveals novel gene signatures in human granulosa cells.

Dhori X, Gioiosa S, Gonfloni S Sci Data. 2024; 11(1):972.

PMID: 39242561 PMC: 11379948. DOI: 10.1038/s41597-024-03715-0.


The HRD1-SEL1L ubiquitin ligase regulates stress granule homeostasis in couple with distinctive signaling branches of ER stress.

Shi W, Ding R, Chen Y, Ji F, Ji J, Ma W iScience. 2024; 27(7):110196.

PMID: 38979013 PMC: 11228786. DOI: 10.1016/j.isci.2024.110196.


Advances in the study of protein folding and endoplasmic reticulum-associated degradation in mammal cells.

Cao H, Zhou X, Xu B, Hu H, Guo J, Ma Y J Zhejiang Univ Sci B. 2024; 25(3):212-232.

PMID: 38453636 PMC: 10918413. DOI: 10.1631/jzus.B2300403.


Doa10/MARCH6 architecture interconnects E3 ligase activity with lipid-binding transmembrane channel to regulate SQLE.

Botsch J, Junker R, Sorgenfrei M, Ogger P, Stier L, von Gronau S Nat Commun. 2024; 15(1):410.

PMID: 38195637 PMC: 10776854. DOI: 10.1038/s41467-023-44670-5.


IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma.

Obacz J, Archambeau J, Lafont E, Nivet M, Martin S, Aubry M Neuro Oncol. 2023; 26(5):858-871.

PMID: 38153426 PMC: 11066906. DOI: 10.1093/neuonc/noad256.